Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has shared an announcement.
Hisamitsu Pharmaceutical Co., Inc. announced the acquisition of 1,765,400 of its own shares, costing approximately 7.1 billion yen, as part of a previously announced plan. This move is part of a broader strategy to repurchase up to 3 million shares by the end of 2025, which could impact the company’s market positioning and shareholder value.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is known for its transdermal therapeutic products and has a significant presence in the Japanese market.
Average Trading Volume: 169,148
Technical Sentiment Signal: Sell
Current Market Cap: Yen299.4B
Learn more about 4530 stock on TipRanks’ Stock Analysis page.